友聯國際(01563.HK)更改財政年度結算日為3月31日
友聯國際(01563.HK)公布,已議決將其財政年度結算日由12月31日更改為3月31日。因此,公司之下一個財政年度結算日將為2024年3月31日,而下一份經審核綜合財務報表將涵蓋2023年1月1日起至2024年3月31日止十五個月期間。
董事會認為,更改財政年度結算日將使公司能夠更高效地合理利用並更充分調動其資源,以編製中期及年度業績公告及報告,此乃鑒於該更改將令集團於2022年8月完成收購煙台南山學院70%權益後,象徵公司自從事民辦高等教育後的一個新里程碑;有充足時間於公司兩個不同的業務板塊收集所有的財務資料以供審核;及消除因中國農曆新年假期的日期的不確定性而為工作流程所帶來的壓力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.